WO2010133377A8 - Fat blends and uses thereof - Google Patents

Fat blends and uses thereof Download PDF

Info

Publication number
WO2010133377A8
WO2010133377A8 PCT/EP2010/003126 EP2010003126W WO2010133377A8 WO 2010133377 A8 WO2010133377 A8 WO 2010133377A8 EP 2010003126 W EP2010003126 W EP 2010003126W WO 2010133377 A8 WO2010133377 A8 WO 2010133377A8
Authority
WO
WIPO (PCT)
Prior art keywords
acid
weight
fat blend
conjugated linoleic
alpha
Prior art date
Application number
PCT/EP2010/003126
Other languages
French (fr)
Other versions
WO2010133377A1 (en
Inventor
Luisa Gambelli
Hiskias Keizer
Sebastiano Banni
Ulrike Schmid
Original Assignee
Stepan Specialty Products, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stepan Specialty Products, Llc filed Critical Stepan Specialty Products, Llc
Priority to EP10725974A priority Critical patent/EP2432328A1/en
Publication of WO2010133377A1 publication Critical patent/WO2010133377A1/en
Publication of WO2010133377A8 publication Critical patent/WO2010133377A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
    • A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/003—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A fat blend comprises alpha-linolenic acid, conjugated linoleic acid and oleic acid. The fat blend comprises: (i) greater than 3 % by weight alpha-linolenic acid; (ii) greater than 12 % by weight conjugated linoleic acid; and (iii) greater than 20 % by weight oleic acid, the percentages being based on the total weight of C16 to C20 fatty acids in the blend. The fat blend may be used for increasing the levels of docosahexaenoic acid in the blood of a subject after oral consumption.
PCT/EP2010/003126 2009-05-22 2010-05-21 Fat blends and uses thereof WO2010133377A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP10725974A EP2432328A1 (en) 2009-05-22 2010-05-21 Fat blends and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09251383 2009-05-22
EP09251383.7 2009-05-22

Publications (2)

Publication Number Publication Date
WO2010133377A1 WO2010133377A1 (en) 2010-11-25
WO2010133377A8 true WO2010133377A8 (en) 2012-01-05

Family

ID=41202607

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/003126 WO2010133377A1 (en) 2009-05-22 2010-05-21 Fat blends and uses thereof

Country Status (2)

Country Link
EP (1) EP2432328A1 (en)
WO (1) WO2010133377A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140037813A1 (en) * 2012-08-02 2014-02-06 Mead Johnson Nutrition Company Nutritional creamer composition
CN103783160A (en) * 2014-02-21 2014-05-14 普洱联众生物资源开发有限公司 Functional yoghourt rich in unsaturated fattyacids
EP3111930B1 (en) * 2015-06-30 2018-04-18 Bierwirth, Rolf Composition for treating depression, bipolar disorders, recurrent medical depressive disorders and other long-term affective disorders
CN115245510A (en) * 2021-04-28 2022-10-28 扬州大学 Application of trans-10, cis-12 conjugated linoleic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0779033T3 (en) * 1995-11-14 2001-11-12 Unilever Nv Edible grease lubricants
EP1618085A1 (en) * 2003-04-25 2006-01-25 Ilshinwells Co., Ltd. Preparation method of conjugated linoleic acid diglycerides

Also Published As

Publication number Publication date
EP2432328A1 (en) 2012-03-28
WO2010133377A1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
GB2459809A (en) Fatty acid formulations and methods of use thereof
WO2007097523A3 (en) Fat composition and preparation methods thereof
WO2009130291A3 (en) Plant seed oil
IN2012DN00760A (en)
MY160810A (en) Plastic oil-and-fat composition
ZA201303962B (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
WO2008147562A3 (en) Dietary formulations and methods for treatment of inflammation and other disorders
EP2946784A3 (en) A therapeutic composition comprising salmon oil and extracts of rosemary and oregano
ATE488143T1 (en) FAT COMPOSITION
WO2008018043A3 (en) Methods of improving bone health and muscle health
WO2011097273A8 (en) Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl l-cysteine
JP2010259437A5 (en)
WO2013123139A8 (en) Methods, compositions, and devices for supplying dietary fatty acid needs
MY143654A (en) Use of a nutritional formulation for promoting catch-up growth
SG184349A1 (en) Methods and lipid compositions for promoting development of gut flora
WO2009062663A3 (en) Infant formula composition
EP2324119A4 (en) Mutant delta5 desaturases and their use in making polyunsaturated fatty acids
HRP20120261T1 (en) Method for reducing the saturated fatty acid content of milk fat, products obtained and applications thereof
WO2010133377A8 (en) Fat blends and uses thereof
ATE547005T1 (en) NUTRITIONAL EDIBLE OIL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
NZ598529A (en) Use of dha, epa or dha-derived epa for treating a pathology associated with cellular oxidative damage
MX2011007222A (en) Nutritional composition for infants.
WO2009111516A3 (en) Stabilization of omega-3 fatty acids in oil-water emulsions
ATE529095T1 (en) MOUTH DISPERSIBLE COMPOSITION WITH POLYUNSATURATED FATTY ACIDS WITHOUT BAD SMELL OR TASTE
NZ609540A (en) Method to produce milk with increased unsaturated fatty acids content

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10725974

Country of ref document: EP

Kind code of ref document: A1

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2010725974

Country of ref document: EP